Table 1 Summary of research papers appraised expression of MCM3AP-AS1 in cell lines

Hepatocellular carcinoma

miR-194-5p, FOXA1

LO2, HepG2, Hep3B, Huh7, SMMC-7721

∆ MCM3AP-AS1: ↓ proliferation, ↑ cell cycle arrest, ↑ apoptosis

[18]

Prostate cancer

miR-876-5p, WNT5A

C4-2, PC-3, LNCaP, DU145, 22Rv1

∆ MCM3AP-AS1: ↓ proliferation, ↑ apoptosis

[19]

miR-543-3p, SLC39A10, PTEN/Akt signaling pathway

PC-3, DU145, 22RV1, LNCaP, WPMY-1

∆ MCM3AP-AS1: ↓ proliferation, ↓ migration, ↓ invasion, ↑ cell cycle arrest, did not affect apoptosis

[20]

NPY1R, MAPK pathway

RWPE1, 22RV1, LNCaP, and DU145

∆ MCM3AP-AS1: ↓ proliferation, ↓ migration, ↓ invasion, ↑ apoptosis

[21]

Breast cancer

miR-28-5p, CENPF

MCF-10A, MCF-7, BT-549, MDA-MB-468, HS578 T

∆ MCM3AP-AS1: ↓ proliferation, ↓ migration, ↓ invasion

[26]

Cervical cancer

miR-93

C-33A, SiHa

↑ MCM3AP-AS1: ↓ proliferation

[22]

Colorectal cancer

miR-545, CDK4

CR4

↑ MCM3AP-AS1: ↑ proliferation, ↓ G1 arrest

[23]

miR-599, ARPP19

HCT-116, SW620, SW480, LoVo, NCM460, 293 T

↑ MCM3AP-AS1: ↑ proliferation, ↑ migration

[24]

miR‐193a‐5p, SENP1

HCT‐8, HCT116, LoVo, HT29, and SW620

∆ MCM3AP-AS1: ↓ proliferation, ↓ migration, ↓ invasion

[25]

Oral squamous cell carcinoma

miR-363-5p

HOK, SCC-9, SCC-15, CAL-27

∆ MCM3AP-AS1: ↓ proliferation, ↓ migration, ↓ invasion

[27]

miR-204-5p, FOXC1

HN-6, SCC-9

∆ MCM3AP-AS1: ↓ proliferation, ↓ migration, ↓ invasion

[28]

Papillary thyroid cancer

miR-211-5p, SPARC

TPC-1, HTH83, 8505C, SW1736, BCPAP

∆ MCM3AP-AS1: ↓ proliferation, ↓ migration, ↓ invasion

[29]

Lymphoma

miR-15a, EIF4E

Daudi, Namalwa

∆ MCM3AP-AS1: ↓ proliferation, ↑ apoptosis, ↑ sensitivity to doxorubicin

[30]

Gastric cancer

miR-708-5p, SGC-7901

GES-1, MGc-803, SGC-7901

∆ MCM3AP-AS1: ↓ proliferation, ↑ apoptosis

[31]

miR-138, FOXC1

AGS, MKN45, NCI-N87, SNU638, GES-1, 293 T

∆ MCM3AP-AS1: ↑ CDDP sensitivity

[32]

Pancreatic cancer

miR-138-5p, FOXK1

HPDE6-C7, PANC-1, BxPC-3, MIA PaCa-2, Capan-2, AsPC-1, HEK-293

↑ MCM3AP-AS1: ↑ proliferation, ↑ migration, ↑ invasion

[33]

Nasopharyngeal carcinoma

miR-34a

FNA, C666-1, 13-9B

↑ MCM3AP-AS1: ↑ proliferation, ↓ apoptosis

[34]

Clear cell renal cell carcinoma

DPP4, E2F1

786-O, Caki-1, UT14, UT48 HK-2

↑ MCM3AP-AS1: ↑ proliferation, ↑ angiogenesis, ↑ inflammatory responses

[35]

Glioblastoma

miR-211, KLF5, AGGF1, PI3K/AKT and ERK1/2 signaling pathways

hCMEC/D3, HEK293T

∆ MCM3AP-AS1: ↓ viability, ↓ migration, ↓ tube formation, ↓ angiogenesis

[36]

Lung cancer

miR‐340‐5p, KPNA4, YY1

A549, H1299, H596, H520

∆ MCM3AP-AS1: ↓ angiogenesis, ↓ migration

[37]

miR-148a, ROCK1

SHP-77

∆ MCM3AP-AS1: ↓ migration, ↓ invasion

[38]

miR-195-5p, E2F3

A549, H358, H1299, H460, H226, BEAS-2B

↑ MCM3AP-AS1: ↑ proliferation, ↑ migration, ↑ invasion ↓ apoptosis

[40]

Endometrioid carcinoma

miR-126, VEGF

HEC-1

↑ MCM3AP-AS1: ↑ migration, ↑ invasion

[39]